Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6291455rdf:typepubmed:Citationlld:pubmed
pubmed-article:6291455lifeskim:mentionsumls-concept:C0042776lld:lifeskim
pubmed-article:6291455lifeskim:mentionsumls-concept:C0028586lld:lifeskim
pubmed-article:6291455lifeskim:mentionsumls-concept:C0035608lld:lifeskim
pubmed-article:6291455lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:6291455lifeskim:mentionsumls-concept:C1947917lld:lifeskim
pubmed-article:6291455lifeskim:mentionsumls-concept:C0376315lld:lifeskim
pubmed-article:6291455lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:6291455pubmed:issue3lld:pubmed
pubmed-article:6291455pubmed:dateCreated1982-12-16lld:pubmed
pubmed-article:6291455pubmed:abstractTextRifampin at concentrations toxic to noninfected cells but not to infected cells is a selective inhibitor of occluded virus of the group A Baculoviridae (nuclear polyhedrosis virus). However, the titer of nonoccluded virus is not affected. Rifampin blocks occlusion until late in the replication cycle (14 to 16 h), and its effects are reversible. Modes of action of polyhedral inclusion body production are unknown.lld:pubmed
pubmed-article:6291455pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6291455pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6291455pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6291455pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6291455pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6291455pubmed:languageenglld:pubmed
pubmed-article:6291455pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6291455pubmed:citationSubsetIMlld:pubmed
pubmed-article:6291455pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6291455pubmed:statusMEDLINElld:pubmed
pubmed-article:6291455pubmed:monthSeplld:pubmed
pubmed-article:6291455pubmed:issn0066-4804lld:pubmed
pubmed-article:6291455pubmed:authorpubmed-author:VaughnJ LJLlld:pubmed
pubmed-article:6291455pubmed:authorpubmed-author:DoughertyE...lld:pubmed
pubmed-article:6291455pubmed:authorpubmed-author:Reichelderfer...lld:pubmed
pubmed-article:6291455pubmed:authorpubmed-author:WeinerR MRMlld:pubmed
pubmed-article:6291455pubmed:issnTypePrintlld:pubmed
pubmed-article:6291455pubmed:volume22lld:pubmed
pubmed-article:6291455pubmed:ownerNLMlld:pubmed
pubmed-article:6291455pubmed:authorsCompleteYlld:pubmed
pubmed-article:6291455pubmed:pagination527-30lld:pubmed
pubmed-article:6291455pubmed:dateRevised2010-9-13lld:pubmed
pubmed-article:6291455pubmed:meshHeadingpubmed-meshheading:6291455-...lld:pubmed
pubmed-article:6291455pubmed:meshHeadingpubmed-meshheading:6291455-...lld:pubmed
pubmed-article:6291455pubmed:meshHeadingpubmed-meshheading:6291455-...lld:pubmed
pubmed-article:6291455pubmed:meshHeadingpubmed-meshheading:6291455-...lld:pubmed
pubmed-article:6291455pubmed:year1982lld:pubmed
pubmed-article:6291455pubmed:articleTitleRifampin inhibition of the occluded virus form of a nuclear polyhedrosis virus.lld:pubmed
pubmed-article:6291455pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6291455lld:pubmed